Abbott Laboratories $ABT shares fell 5% premarket after its Q3 outlook fell short of consensus 📉.
🔹 Q2 revenue beat expectations at $11.1 billion
🔹 Q3 earnings per share forecast in the $1.28-$1.32 range, below consensus $1.33